Literature DB >> 31985056

Circular RNA; a new biomarker for breast cancer: A systematic review.

Shima Jahani1,2, Elahe Nazeri1, Keivan Majidzadeh-A1, Mona Jahani3, Rezvan Esmaeili1.   

Abstract

Circular RNAs (circRNAs) were recently discovered as a looped subset of competing endogenous RNAs, with an ability to regulate gene expression by microRNA sponging. There are several studies on their potential roles in cancer development, such as colorectal cancer and basal cell carcinoma. However, there is still a significant gap in the knowledge about circRNA functions in breast cancer (BC) progression. The current study systematically reviewed circRNA biogenesis and their potential roles as a novel biomarker in BC on published studies of the MEDLINE®/PubMed, Cochrane®, and Scopus® databases. The obtained results showed a general dysregulation of circRNAs expression in BC cells with a cell-type and stage-specific manner. The potential connection between circRNAs and BC cell proliferation, apoptosis, metastasis, and chemotherapy sensitivity and resistance were discussed.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; circular RNA; control of apoptosis; drug resistance; long noncoding RNA; noncoding RNA

Mesh:

Substances:

Year:  2020        PMID: 31985056     DOI: 10.1002/jcp.29558

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  Circular GOLPH3 RNA exerts oncogenic effects in vitro by regulating the miRNA-1299/LIF axis in oral squamous cell carcinoma.

Authors:  Chen Zou; Xia Li; Haigang Wei; Siyuan Wu; Jing Song; Zhe Tang; Hailing Luo; Xiaozhi Lv; Yilong Ai
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  Blocking circ_0000520 Suppressed Breast Cancer Cell Growth, Migration and Invasion Partially via miR-1296/SP1 Axis Both in vitro and in vivo.

Authors:  Hongliang Zang; Yuhui Li; Xue Zhang; Guomin Huang
Journal:  Cancer Manag Res       Date:  2020-08-25       Impact factor: 3.989

3.  Circular RNA OMA1 regulates the progression of breast cancer via modulation of the miR‑1276/SIRT4 axis.

Authors:  Lingli Xu; Ke Xu; Lijun Xiang; Jiamei Yan
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

Review 4.  Disease-Associated Circular RNAs: From Biology to Computational Identification.

Authors:  Min Tang; Ling Kui; Guanyi Lu; Wenqiang Chen
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

Review 5.  Recent advances in understanding circular RNAs.

Authors:  Constanze Ebermann; Theodor Schnarr; Sabine Müller
Journal:  F1000Res       Date:  2020-06-29

Review 6.  Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.

Authors:  Yan Shi; Daihong Ding; Rongfeng Qu; Yan Tang; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2020-11-24       Impact factor: 4.147

7.  Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Authors:  Qi Shao; Yong Huang; Cai Zhang; Xiaochan Gao; Shiyang Gao
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

8.  Circular RNA as a Potential Biomarker for Melanoma: A Systematic Review.

Authors:  Keyun Tang; Hanlin Zhang; Yaqi Li; Qiuning Sun; Hongzhong Jin
Journal:  Front Cell Dev Biol       Date:  2021-04-01

9.  CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to adriamycin by sponging miR‑145 and regulating NRAS.

Authors:  Jingjing Chen; Peng Shi; Jinghua Zhang; Yufeng Li; Jie Ma; Yudong Zhang; Hong Liu
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

10.  Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3.

Authors:  Farzaneh Darbeheshti; Elham Zokaei; Yaser Mansoori; Sima Emadi Allahyari; Zeeba Kamaliyan; Sepideh Kadkhoda; Javad Tavakkoly Bazzaz; Nima Rezaei; Abbas Shakoori
Journal:  Cancer Cell Int       Date:  2021-06-14       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.